Previous 10 | Next 10 |
Innovative transdermal technology enables delivery of abaloparatide molecule – a peptide - across the skin Trial success followed by regulatory approval would provide a completely unique drug administration option for postmenopausal women with osteoporosis. wearABLe progress ...
WALTHAM, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced its participation in the following conferences in September 2020. Radius Health management will host virtual meetings with investors during the Citi 15 th Annual...
TYMLOS ® patent extended to 2031, adding approximately 3½ years to the TYMLOS-SC patent life Enrollment completed for ATOM Phase 3 study assessing the efficacy and safety of abaloparatide-SC in males with osteoporosis WALTHAM, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Radiu...
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q2 2020 Earnings Call Aug 10, 2020 , 8:30 a.m. ET Operator Continue reading
Radius Health, Inc. (RDUS) Q2 2020 Results Earnings Conference Call August 10, 2020, 8:30 AM ET Company Participants Elhan Webb - Vice President, Investor Relations Kelly Martin - President and CEO Owen Hughes - Chairman Pepe Carmona - Chief Financial Officer Conference Call...
The following slide deck was published by Radius Health, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Radius Health (NASDAQ: RDUS ) : Q2 Non-GAAP EPS of -$0.67 misses by $0.16 ; GAAP EPS of -$0.95 misses by $0.21 . More news on: Radius Health, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
WALTHAM, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced the appointment of Sean Murphy to its Board of Directors with immediate effect. Sean has several decades of experience in the indus...
TYMLOS ® U.S. net sales of $50 million, with 22% year over year growth Completion of enrollment in ATOM Phase 3 expected this week Phase 3 Trials: wearABLe and EMERALD remain on track Conference call scheduled for 8:30 a.m. ET today WALTHAM, Mass., Aug. 10, 2020 (...
REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Radius Health, Inc. (Radius, Nasdaq: RDUS) to pursue regulatory approval of the Guardant360 ® CDx as a companion diagnostic for elacestrant (R...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...